@TJasonSimoni
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Hospitalist and Clinical Assistant Professor @LSUHealthNO and @UMCNO🐯🫀🟣🟡|
Lafayette, LA
Joined May 2012
- Tweets428
- Following710
- Followers475
- Likes8.9K
Pinned Tweet
With Match Week at a close, I wanted celebrate my wonderful fiancée @nadjellaoopamen and our successful Couple’s Match.
Navigating this cycle with her after going unmatched in 2021 has been an enormous feat of love and teamwork.
1/🧵
#Match2022 #MatchAResident #MedTwitter
Jason Simon, MD retweeted
I try to remind med students and practicing physicians who consider scaling back or giving up clinical careers for content creation how unstable it can be. People view content creation as freedom. You can work for yourself on your own schedule. That's true to a certain degree, but keep in mind that you don't own your audience. TikTok owns it. YouTube owns it. One change in the algorithm could significantly impact your livelihood. A few years ago, YT reclassified shorts as videos that are under 3 minutes instead of 60 seconds. Overnight, my social media income was cut in half. It didn't matter too much to me, because I still work full time as an ophthalmologist.
I know I shit on the healthcare system and point out all the terrible things we deal with as physicians, but for all its faults, practicing medicine is an incredibly stable career, much more stable than content creation.
I will never begrudge anybody for pursuing their passions. Some people just can't practice medicine anymore, and are looking for any way out they can find. Content creation is a way out, and hardworking, talented people will make it happen. I just want people to know the grass isn't always greener...
Jason Simon, MD retweeted
#CardioNugget
The term “Type 2 NSTEMI” is not officially used anymore in formal definitions. Instead, the correct terminology is:
✅ Type 2 MI
This refers to myocardial infarction due to an imbalance between oxygen supply and demand not caused by a primary coronary event (e.g., vasospasm, anemia, tachyarrhythmia, hypotension). It can present with or without ST-elevation on ECG.
Quick refresher from the Fourth Universal Definition of MI:
-Type 1 MI: Plaque rupture with thrombus.
-Type 2 MI: Supply-demand mismatch causing ischemia not due to atherothrombosis.
#CardioNuggets #MedEd #CardioTwitter
Jason Simon, MD retweeted
Honey, stop what you're doing, new hyponatremia research just dropped!
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
jamanetwork.com/journals/jam…
Jason Simon, MD retweeted
New @Nature
A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells
nature.com/articles/s41586-0…
@vonMeyenn @laurahinte
Jason Simon, MD retweeted
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM
🥸The SUMMIT trial - @AHAScience
😱 Summary
👇👇👇
Jason Simon, MD retweeted
After surgical implantation of a bioprosthetic valve, obtain a TTE at 5 years, 10 years, and then annually--even without a clinical change (Class IIa). At/after 10 years, the incidence of clinically significant valve dysfunction increases substantially.
#CVBoardPearl #MedX
Jason Simon, MD retweeted
In a post-hoc analysis of #PARADIGM-HF & #PARAGON-HF, continuation of sacubtril/valsartan when eGFR falls <30mL/min/1.73m2 is assoc w/ persistent clinical benefit & no incremental safety risk across all #LVEF. bit.ly/3A4aQjs
#JACCHF #HeartFailure #GDMT @safchat @mvaduganathan @scottdsolomon
These are the big four Q’s for residency interviews.
Jason Simon, MD retweeted
🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present.
Read more key points from a state-of-the-art review on AiCM: bit.ly/4e8Mkgn
Needless to say technically difficult study (user dependent 😂). But taking every opportunity I can to learn bedside echos. #CardioTwitter
Appreciate tips on getting better views/resolutions?
Jason Simon, MD retweeted
8. PREVENT Trial: In patients with non-flow-limiting vulnerable coronary plaques, preventive PCI reduced major adverse CV events arising from high-risk vulnerable plaques, compared with optimal medical therapy alone.
Jason Simon, MD retweeted
5. STEP-HFpEF DM Trial: Among patients with obesity-related HFpEF and T2DM, semaglutide led to larger reductions in HF–related symptoms and physical limitations and greater weight loss than placebo at 1 year.
Jason Simon, MD retweeted
The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.
Read more: bit.ly/3xuHWrl
#ACC24
Obligatory post. First time feels here at #acc24. Such a great opportunity to be here with vast learning and stellar people. Hope to be back at next year’s meeting!
Jason Simon, MD retweeted
Goodnight #ACC24! I can’t wait to see you all tomorrow. 🩷
Don’t forget there are limited edition Arties for sale in the ACC Store while supplies last.
Jason Simon, MD retweeted
Residency Match 2024-25 starts now.
Dr. @gulrayzahmed prepared a timeline for residency match that holds true even today. Please review this and start planning. Obviously it is generalized timeline and may not fit to everyone's situation. So review and then go from there.
1/n